Klein Matthew B.
- SEC CIK
- 0001808968
In the past year, 10 open-market sale filings worth $4.41M and no purchases.
Current role at each company
- PTCT PTC Therapeutics, Inc.CHIEF EXECUTIVE OFFICERas of Aug 6, 2026
- CLPT ClearPoint Neuro, Inc.Directoras of May 26, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.41M
- 10 filings
- Net
- −$4.41M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Klein Matthew B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PTCT PTC Therapeutics, Inc.
CHIEF EXECUTIVE OFFICER23 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 (view filing)5:20 PM ET | Aug 4 | 2 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −10.3K | $68.57 | −$705.7K | −2.6%383.9K after | 10b5-1 |
| May 15, 2026 (view filing) | May 14 | 1 day | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −12.6K | $72.95 | −$917.2K | −3.1%394.0K after | 4 lots10b5-1 |
| Apr 23, 2026 (view filing) | Apr 21 | 2 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −2.85K | $70.91 | −$202.1K | −0.7%394.1K after | 10b5-1 |
| Mar 13, 2026 (view filing) | Mar 12 | 1 day | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −2.66K | $64.08 | −$170.6K | −0.7%396.9K after | 10b5-1 |
| Feb 20, 2026 (view filing) | Feb 18 | 2 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −7.37K | $69.36 | −$511.3K | −1.9%387.1K after | 10b5-1 |
| Jan 12, 2026 (view filing) | Jan 8 | 4 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −2.51K | $76.45 | −$192.2K | −0.6%394.5K after | 10b5-1 |
| Jan 8, 2026 (view filing) | Jan 6-7 | 2 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −8.16K | $77.15 | −$629.9K | −2.0%397.0K after | 2 lots10b5-1 |
| Jan 2, 2026 (view filing) | Dec 30, 2025 | 3 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −8.09K | $76.64 | −$619.9K | −2.3%341.9K after | 10b5-1 |
| Dec 3, 2025 (view filing) | Dec 2 | 1 day | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −3.43K | $79.07 | −$271.1K | −1.0%350.0K after | 10b5-1 |
| Aug 5, 2025 (view filing) | Aug 5 | Same day | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −10.7K | $51.74 | −$555.6K | −3.1%337.8K after | 10b5-1 |
CLPT ClearPoint Neuro, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 (view filing) | May 21 | 5 days | Klein Matthew B.Director | SSale | −16.0K | $11.59 | −$185.4K | −25.4%46.9K after |